Product Information
OSELTAMIVIR PHOS 30 MG CAPSULE is a generic product labeled by Alvogen Inc., priced at $0.7127 per EA under NDC 47781046813. Its NADAC has been published 488 times since Feb 22, 2017.
Strength
30 mg/1
Manufacturer
Alvogen Inc.NDC
47781046813
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
OSELTAMIVIR PHOSPHATEApproval Type
Generic (ANDA)
FDA Application
ANDA202595On Market Since
12/12/2016
Pharmacological Classes
Price Statistics
The NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has been published 488 times since Feb 22, 2017, and over the history we have for it it has declined 91.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7127 per EA |
|---|---|
| All-time high | $8.7338 (May 10, 2017) |
| All-time low | $0.6013 (Aug 20, 2025) |
| 52-week high | $0.8323 |
| 52-week low | $0.6013 |
| Median price | $2.7788 |
| Average price | $3.3866 |
| Largest weekly change | +62.9% (Jan 25, 2023) |
| Weeks tracked | 488 |
| Tracking since | Feb 22, 2017 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of OSELTAMIVIR PHOS 30 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR PHOS 30 MG CAPSULE, manufactured by Alvogen Inc., is $0.7127 per EA (NDC 47781046813), effective Jun 24, 2026.
How has the price of OSELTAMIVIR PHOS 30 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has declined 91.8%. It has been tracked across 488 weekly CMS publications since Feb 22, 2017.
What are the highest and lowest recorded NADAC prices for OSELTAMIVIR PHOS 30 MG CAPSULE?
Since Feb 22, 2017, the NADAC for OSELTAMIVIR PHOS 30 MG CAPSULE has ranged from a low of $0.6013 (Aug 20, 2025) to a high of $8.7338 (May 10, 2017), with a median of $2.7788 per EA.
Are there cheaper alternatives to OSELTAMIVIR PHOS 30 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as OSELTAMIVIR PHOS 30 MG CAPSULE, but none are currently priced below it.
Who manufactures OSELTAMIVIR PHOS 30 MG CAPSULE?
OSELTAMIVIR PHOS 30 MG CAPSULE (NDC 47781046813) is labeled by Alvogen Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification